Gramicidin inhibits cholangiocarcinoma cell growth by suppressing EGR4

References

• Squadroni M, Tondulli L, Gatta G, et al. Cholangiocarcinoma [Review]. Cr Rev Oncol-Hem. 2017;116:11–31.
   PubMed Web of Science ®Google Scholar
• Le Faouder J, Gigante E, Leger T, et al. Proteomic landscape of cholangiocarcinomas reveals three different subgroups according to their localization and the aspect of Non-Tumor liver. Prot Clin Appl. 2019;13(1):e1800128.
   Web of Science ®Google Scholar
• Patel T. Cholangiocarcinoma–controversies and challenges [Review]. Nat Rev Gastroenterol Hepatol. 2011;8(4):189–200.
   PubMed Web of Science ®Google Scholar
• Lafaro KJ, Cosgrove D, Geschwind JF, et al. Multidisciplinary care of patients with intrahepatic cholangiocarcinoma: updates in management [review]. Gastroent Res Pract. 2015;2015:860861.
   Google Scholar
• Morement H, Harrison R, Taylor-Robinson SD. The multidisciplinary team meeting in the UK from the patients' perspective: comments and observations from cholangiocarcinoma patients and their families. Int J Gen Med. 2017;10:305–310.
   PubMed Web of Science ®Google Scholar
• Ong CK, Subimerb C, Pairojkul C, et al. Exome sequencing of liver fluke-associated cholangiocarcinoma [Research Support, Non-U.S. Gov't]. Nat Genet. 2012;44(6):690–693.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Pawlik TM, Anders RA, et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Nat Genet. 2013;45(12):1470–1473.
   PubMed Web of Science ®Google Scholar
• Dubos RJ, Cattaneo C. Studies on a bactericidal agent extracted from a soil bacillus: Iii. preparation and activity of a protein-free fraction. J Exp Med. 1939;70(3):249–256.
   PubMedGoogle Scholar
• Kelkar DA, Chattopadhyay A. The gramicidin ion channel: a model membrane protein [Research Support, Non-U.S. Gov't Review]. Biochim Biophys Acta. 2007;1768(9):2011–2025.
   PubMed Web of Science ®Google Scholar
• David JM, Owens TA, Barwe SP, et al. Gramicidin A induces metabolic dysfunction and energy depletion leading to cell death in renal cell carcinoma cells [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Mol Cancer Ther. 2013;12(11):2296–2307.
   PubMed Web of Science ®Google Scholar
• Majd S, Yusko EC, MacBriar AD, et al. Gramicidin pores report the activity of membrane-active enzymes [Research Support, N.I.H., extramural research support, Non-U.S. Gov't]. J Amer Chem Soc. 2009;131(44):16119–16126.
   PubMed Web of Science ®Google Scholar
• David JM, Rajasekaran AK. Gramicidin A: a new mission for an old antibiotic. J Kidney Cancer VHL. 2015;2(1):15–24.
   PubMed Web of Science ®Google Scholar
• David JM, Owens TA, Inge LJ, et al. Gramicidin A blocks tumor growth and angiogenesis through inhibition of hypoxia-inducible factor in renal cell carcinoma [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Mol Cancer Ther. 2014;13(4):788–799.
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data [Research Support, Non-U.S. Gov't]. Nucl Acids Res. 2014;42(D1):D92–7.
   PubMed Web of Science ®Google Scholar
• Yang JH, Li JH, Shao P, et al. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data [Research Support, Non-U.S. Gov't]. Nucleic Acids Res. 2011;39(suppl_1):D202–9.
   PubMedGoogle Scholar
• Farshidfar F, Zheng S, Gingras MC, et al. Integrative genomic analysis of cholangiocarcinoma Identifies Distinct IDH-Mutant molecular profiles [research support, N.I.H., extramural research support, Non-U.S. Gov't]. Cell Rep. 2017;18(11):2780–2794.
   PubMed Web of Science ®Google Scholar
• Sia D, Losic B, Moeini A, et al. Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Nat Commun. 2015;6(1):6087.
   PubMed Web of Science ®Google Scholar
• Matsuo T, Dat Le T, Komatsu M, et al. Early growth response 4 is involved in cell proliferation of small cell lung cancer through transcriptional activation of its downstream genes [Research Support, Non-U.S. Gov't]. PloS One. 2014;9(11):e113606.
   PubMed Web of Science ®Google Scholar
• Wieland GD, Nehmann N, Muller D, et al. Early growth response proteins EGR-4 and EGR-3 interact with immune inflammatory mediators NF-kappaB p50 and p65 [Research Support, Non-U.S. Gov't]. J Cell Sci. 2005;118(14):3203–3212.
   PubMed Web of Science ®Google Scholar
• Niu RN, Shang XP, Teng JF. Overexpression of Egr2 and Egr4 protects rat brains against ischemic stroke by downregulating JNK signaling pathway. Biochimie. 2018;149:62–70.
   PubMed Web of Science ®Google Scholar